This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Looking to boost your income? Discover effective ways to increase income quickly with our expert tips.
21,712 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
ZIM shares hover near $27.54, well under Hapag-Lloyd’s $35 cash proposal. The discount reflects regulatory risk aroun...
As Cardano prepares to roll out its Midnight privacy network this week, the cardano shorts spike highest reading sinc...
Shiba Inu ceded its top meme-coin ranking to MemeCore as interest shifts in the volatile meme-coin market. This repor...
AI stocks are creating big opportunities, but a broad tech ETF like Vanguard's flagship tech might not deliver your A...
Binance’s delisting of five smaller tokens sparked a brutal price collapse altcoins, with double-digit losses across ...
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
The Strategic Petroleum Reserve posted what may be its largest weekly withdrawal, about 10 million barrels, pushing s...
A single wall street analyst thinks Pfizer's stock could spark a meaningful rally. Learn the catalysts, risks, and ho...
A sudden jump in Kratos Defense shares drew attention as policy headlines swirled. This guide explains what happened,...
Oil prices fell after Trump signaled a near term peace agreement, with front month WTI and Brent easing from earlier ...
A proposed social media tax in Illinois has critics calling it illinois’ social media shambles. This in-depth look ex...